Vol. 49 | No. 1 | January-June 2021Back

Open Access

The Economic Burden of Hospitalization for Cardiac Arrhythmias Requiring Implantable Cardioverter Defibrillator and Radiofrequency Ablation Among Adult Filipinos—Its Clinical and Equity Implications and Budget Impact Analysis of Proposed Revised PhilHealth Case Rates for Cardioverter-Defibrillator Implantation and Radiofrequency Ablation

Bernadette A. Tumanan-Mendoza, Victor L. Mendoza, Eden A. Gabriel, Giselle G. Gervacio, Erdie C. Fadreguilan, Michael-Joseph F. Agbayani, Gladys Ruth S. David, Luigi Pierre S. Segundo, Carlos E. De Las Llagas, Magdalena J. Lagamayo, Felix Eduardo R. Punzalan, April Ann A. Bermudez-delos Santos, Noemi S. Pestaño
Jun 2021 DOI 10.69944/pjc.6f463ba151

More Info

Bernadette A. Tumanan-Mendoza MD MSc MHE1,2 | Victor L. Mendoza MD MSc3,4 | Eden A. Gabriel  MD5,6 | Giselle G. Gervacio MD1,5,7 | Erdie C. Fadreguilan MD5 | Michael-Joseph F. Agbayani MD1,5,7 |  Gladys Ruth S. David MD5,6 | Luigi Pierre S. Segundo MD8 | Carlos E. De Las Llagas MD9 | Magdalena  J. Lagamayo MD10 | Felix Eduardo R. Punzalan MD MSc1,7 | April Ann A. Bermudez-delos Santos MD1 |  Noemi S. Pestaño MD1 

1Section of Cardiology, Department of Internal Medicine, Manila Doctors Hospital; 2Department of Clinical Epidemiology, University of the Philippines College of Medicine; 3Section of Cardiology, Department of Internal Medicine, De La Salle University Medical Center, Dasmariñas, Cavite; 4Department of Physiology, De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite; 5Division of Electrophysiology, Philippine Heart Center; 6Cardinal Santos Medical Center; 7Division of Cardiovascular Medicine, Department of Medicine, Philippine General  Hospital, University of the Philippines College of Medicine; 8The Medical City, Asian Hospital and Medical Center; 9St Luke’s Medical Center-Global City, Daniel Mercado Medical Center Tanauan City; 10Our Lady of Lourdes Hospital

References
  1. Shapira AR. Catheter ablation of supraventricular arrhythmias and atrial fibrillation. Am Fam Physician 2009;80:1089-1094.
  2. Calkins H, Kumar VKA, Francis J. Radiofrequency catheter ablation of supraventricular tachycardia. Indian Pacing Electrophysiol J 2002;2:45-49.
  3. Katritsis DG, Zografos T, Katritsis GD, et al. Catheter ablation vs. antiarrhythmic drug therapy in patients with symptomatic atrioventricular nodal re-entrant tachycardia: a randomized, controlled trial. Europace 2017;19:602-606.
  4. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/ HRS guideline for the management of adult patients with supraventricular tachycardia. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2016;133:e506-3574. doi: 10.1161/ CIR.0000000000000311.
  5. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2020;41:655-720. doi:10.1093/eurheartj/ehz467.
  6. Epstein, AE, DiMarco, JP, Ellenbogen, KA., et al. ACC/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2008;117:e350-e408.doi: 10.1161/CIRCUALTIONAHA.108.189742.
  7. The revised implementing rules and regulations of the National Health Insurance Act of 2013 (RA 7875 as Amended by RA 9241 and 10606). https://www.philhealth. gov.ph/about_us/IRR_NHIAct_2013.pdf. Accessed June 7, 2020.
  8. PhilHealth. 2017 Stats & Charts. https://www.philhealth. gov.ph/about_us/statsncharts/snc2017.pdf. Accessed June 7, 2020.
  9. PhilHealth. 2018 Stats & Charts. https://www.philhealth. gov.ph/about_us/statsncharts/snc2018.pdf. Accessed June 7, 2020.
  10. 2016 PhilHealth Relative Value Scale codes/procedures. https://www.philhealth.gov.ph/circulars/2013/annexes/ circ35_2013/Annex2_ListOfProcedureCaseRates.pdf. Accessed June 7, 2020.
  11. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford, UK: Oxford University Press; 2015.
  12. Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health 2014;17:5-14.
  13. Philippine Statistics Authority Philippine National Health Accounts. Total health expenditures grew by 8.0 percent in 2017. https://psa.gov.ph/pnha-press-release/ node/136135. Accessed June 9, 2020.
  14. Philippine Statistics Authority Philippine National Health Accounts. Total health expenditures grew by 8.3 percent in 2018. https://psa.gov.ph/pnha-press-release/ node/144466. Accessed June 9, 2020.
  15. Philippine Statistics Authority. Annual family income is estimated at PHP313 thousand, on average, in 2018. https://psa.gov.ph/content/annual-family-income estimated-php-313-thousand-average-2018. Accessed June 8, 2020.
  16. Gervacio-Domingo G, Punzalan FE, Amarillo ML, Dans A. Sudden unexplained death during sleep occurred commonly in the general population in the Philippines: a substudy of the National Nutrition and Health Survey. J Clin Epidemiol 2007;60:567-571.
  17. Gervacio-Domingo G, Isidro J, Tirona J, et al. The Brugada type 1 electrocardiographic pattern is common among Filipinos. J Clin Epidemiol 2008;61:1067-1072.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.